{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:28:04Z","timestamp":1790263684623,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":1676,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1074\/jbc.m115.672790","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T01:36:51Z","timestamp":1449625011000},"page":"2799-2811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism"],"prefix":"10.1016","volume":"291","author":[{"given":"Ruwanthi N.","family":"Gunawardane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preston","family":"Fordstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek E.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Masterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margrit","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.672790_bib1","first-page":"e28","article-title":"Heart disease and stroke statistics: 2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1074\/jbc.M115.672790_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"},{"key":"10.1074\/jbc.M115.672790_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrd4279","article-title":"HDL-targeted therapies: progress, failures and future","volume":"13","author":"Kingwell","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.M115.672790_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrcardio.2009.94","article-title":"Update on strategies to increase HDL quantity and function","volume":"6","author":"Duffy","year":"2009","journal-title":"Nat. Rev. Cardiol"},{"key":"10.1074\/jbc.M115.672790_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithins:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M115.672790_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcm.2010.03.007","article-title":"Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans","volume":"20","author":"Calabresi","year":"2010","journal-title":"Trends Cardiovasc. Med"},{"key":"10.1074\/jbc.M115.672790_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-2275(20)39245-2","article-title":"Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins","volume":"7","author":"Glomset","year":"1966","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M115.672790_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11883-011-0171-6","article-title":"Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?","volume":"13","author":"Rousset","year":"2011","journal-title":"Curr. Atheroscler. Rep"},{"key":"10.1074\/jbc.M115.672790_bib9","doi-asserted-by":"crossref","first-page":"11448","DOI":"10.1073\/pnas.93.21.11448","article-title":"Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis","volume":"93","author":"Hoeg","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.672790_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/01.ATV.20.2.450","article-title":"LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits","volume":"20","author":"Brousseau","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.M115.672790_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/gt.2009.8","article-title":"Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions","volume":"16","author":"Van Craeyveld","year":"2009","journal-title":"Gene Ther"},{"key":"10.1074\/jbc.M115.672790_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.febslet.2004.06.017","article-title":"Increased plasma HDL cholesterol levels and biliary cholesterol excretion in hamster by LCAT overexpression","volume":"570","author":"Zhang","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.M115.672790_bib13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nm0797-744","article-title":"High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase","volume":"3","author":"B\u00e9rard","year":"1997","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M115.672790_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.672790_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCGENETICS.108.773168","article-title":"Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and apolipoprotein B among 6382 white women in genome-wide analysis with replication","volume":"1","author":"Chasman","year":"2008","journal-title":"Circ. Cardiovasc. Genet"},{"key":"10.1074\/jbc.M115.672790_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ng.327","article-title":"Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants","volume":"41","author":"Myocardial Infarction Genetics Consortium","year":"2009","journal-title":"Nature genetics"},{"key":"10.1074\/jbc.M115.672790_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0005-2760(67)90064-1","article-title":"Familial serum-cholesterol esterification failure: a new inborn error of metabolism","volume":"144","author":"Norum","year":"1967","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M115.672790_bib18","first-page":"922","article-title":"Fish-eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia","volume":"2","author":"Carlson","year":"1979","journal-title":"Lancet"},{"key":"10.1074\/jbc.M115.672790_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.ATV.16.2.294","article-title":"Two novel molecular defects in the LCAT gene are associated with fish eye disease","volume":"16","author":"Kuivenhoven","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.M115.672790_bib20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCULATIONAHA.105.540427","article-title":"Compromised LCAT function is associated with increased atherosclerosis","volume":"112","author":"Hovingh","year":"2005","journal-title":"Circulation"},{"key":"10.1074\/jbc.M115.672790_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2004.07.018","article-title":"Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up","volume":"177","author":"Ayyobi","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1074\/jbc.M115.672790_bib22","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/01.ATV.0000175751.30616.13","article-title":"The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families","volume":"25","author":"Calabresi","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.M115.672790_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.848143","article-title":"Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans","volume":"120","author":"Calabresi","year":"2009","journal-title":"Circulation"},{"key":"10.1074\/jbc.M115.672790_bib24","first-page":"326","article-title":"Lecithin:cholesterol acyltransferase activity in patients with acute myocardial infarction and coronary heart disease","volume":"18","author":"Solaji\u0107-Bozicevi\u0107","year":"1991","journal-title":"Artery"},{"key":"10.1074\/jbc.M115.672790_bib25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1373\/clinchem.2009.139931","article-title":"High pre-\u03b21 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol","volume":"56","author":"Sethi","year":"2010","journal-title":"Clin. Chem"},{"key":"10.1074\/jbc.M115.672790_bib26","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2008-1213","article-title":"Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness","volume":"93","author":"Dullaart","year":"2008","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.M115.672790_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1194\/P900038-JLR200","article-title":"Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study","volume":"51","author":"Holleboom","year":"2010","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M115.672790_bib28","first-page":"S1175","article-title":"Lecithin cholesterol acyltransferase promotes reverse cholesterol transport and attenuates atherosclerosis progression in New Zealand white rabbits","volume":"120","author":"Zhou","year":"2009","journal-title":"Circulation"},{"key":"10.1074\/jbc.M115.672790_bib29","unstructured":".Zhou M, F. P., Zhang J, Meininger D, Schwarz M, Kayser F, Shan B., (2008) Novel small molecule LCAT activators raise HDL levels in rodent models, in arteriosclerosis. in Thrombosis and Vascular Biology Annual Conference, June 14\u201317, p. e65, Atlanta, Georgia."},{"key":"10.1074\/jbc.M115.672790_bib30","unstructured":".Schreiber, J. R., and Kamboj, K. K., (July 21, 2011) Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic XenoMouse, U.S. Patent Application 08\/759,620,"},{"key":"10.1074\/jbc.M115.672790_bib31","unstructured":".Belmont, W., Wong, H.C., Wittman, V. P., and Weidanz, J. A., (June 13, 2012) Transgenic animals comprising a humanized immune system, International Patent Application WO 98\/24893,"},{"key":"10.1074\/jbc.M115.672790_bib32","unstructured":".Green, L. L., Ivanov, V. E., and Davis, C. G., (December 21, 2000) Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions, International Patent Application WO 00\/76310,"},{"key":"10.1074\/jbc.M115.672790_bib33","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.123.4.1548","article-title":"A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines","volume":"123","author":"Kearney","year":"1979","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.672790_bib34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-2275(20)38100-1","article-title":"Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity","volume":"23","author":"Chen","year":"1982","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M115.672790_bib35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.metabol.2011.08.006","article-title":"Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters","volume":"61","author":"Chen","year":"2012","journal-title":"Metab. Clin. Exp"},{"key":"10.1074\/jbc.M115.672790_bib36","unstructured":".Boone, T., Meininger, D. K., Schwartz, M., Shen W., Zhou, M., (April 14, 2015) Modified lecithin-cholesterol acyltransferase enzymes, U.S. Patent US9006408 B2,"},{"key":"10.1074\/jbc.M115.672790_bib37","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1194\/jlr.M059873","article-title":"The high-resolution crystal structure of human LCAT","volume":"56","author":"Piper","year":"2015","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M115.672790_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"Battye","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M115.672790_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","author":"Evans","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M115.672790_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M115.672790_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr"},{"key":"10.1074\/jbc.M115.672790_bib42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1107\/S0907444998003254","article-title":"Crystallography & NMR system: a new software suite for macromolecular structure determination","volume":"54","author":"Br\u00fcnger","year":"1998","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M115.672790_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M115.672790_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M115.672790_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M115.672790_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2013.03.011","article-title":"An extended range generic immunoassay for total human therapeutic antibodies in preclinical pharmacokinetic studies","volume":"393","author":"Hall","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"10.1074\/jbc.M115.672790_bib47","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/pro.2373","article-title":"Recombinant human lecithin-cholesterol acyltransferase Fc fusion: analysis of N- and O-linked glycans and identification and elimination of a xylose-based O-linked tetrasaccharide core in the linker region","volume":"22","author":"Spahr","year":"2013","journal-title":"Protein Sci"},{"key":"10.1074\/jbc.M115.672790_bib48","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/S0021-9258(18)94128-1","article-title":"Human plasma lecithin-cholesterol acyltransferase. Inhibition of the phospholipase A2-like activity by sn-2-difluoroketone phosphatidylcholine analogues","volume":"264","author":"Jauhiainen","year":"1989","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.672790_bib49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3229","article-title":"Development trends for human monoclonal antibody therapeutics","volume":"9","author":"Nelson","year":"2010","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.M115.672790_bib50","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1016\/S0021-9258(19)62718-3","article-title":"Human plasma lecithin-cholesterol acyltransferase: an elucidation of the catalytic mechanism","volume":"261","author":"Jauhiainen","year":"1986","journal-title":"J. Biol. Chem"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820342708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820342708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.672790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T02:42:00Z","timestamp":1692153720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820342708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0021925820342708"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.672790","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M115.672790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}